Regeneron Company Updates | Glassdoor.co.in

Company Updates

  • We are using our end-to-end antibody technologies to discover and develop brand new therapeutic antibodies for this disease. Our new COVID-19 drug candidate will be studied for its potential both to prevent infection and to treat people already infected with the virus.

Work at Regeneron? Share Your Experiences

Regeneron
 
Click to Rate
or